top of page
Search
Gustavo Dziewczapolski, Scientific Director
Sep 30, 20242 min read
One Step Closer to LAMA2-RD Clinical Trials: Modalis Therapeutics
Modalis Therapeutics program for LAMA2-RD gene therapy granted Rare Pediatric Disease Designation by FDA.
Gustavo Dziewczapolski, Scientific Director
Sep 23, 20245 min read
Research Update: LMNA
We are honored to support groundbreaking discoveries related to LMNA-CMD.
Cure CMD
Sep 1, 20242 min read
Workshop to Establish Subtype-Specific Care Recommendations for Congenital Muscular Dystrophy
We are thrilled to announce a new clinical workshop focused on establishing CMD subtype-specific care recommendations.
Gustavo Dziewczapolski, Scientific Director
Aug 7, 20243 min read
Research Update: Dystroglycanopathy
We are honored to support groundbreaking discoveries related to Dystroglycanopathy.
bottom of page